![](https://www.forbes.com.au/wp-content/uploads/2024/07/GettyImages-978796586.jpg?w=1352)
Meet the new biotech billionaire putting pig hearts in humans
The planet’s latest billionaire is a helicopter-flying transgender woman who made a fortune saving her daughter’s life.
The planet’s latest billionaire is a helicopter-flying transgender woman who made a fortune saving her daughter’s life.
President Joe Biden tested positive for COVID-19 on Wednesday, the White House said, hours after he appeared at an event in Las Vegas.
Women with endometriosis may have a “markedly increased” risk of developing ovarian cancer, according to a study by the JAMA Network
A class of diabetes and weight loss drugs that includes Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro could also help protect against a variety of cancers, according to new research published Friday, adding to mounting evidence that injections offer numerous additional health benefits as pressure builds for insurers and public health providers to cover the popular medication in spite of persistent shortages and cost concerns.
Patients who used the drug experienced more time without experiencing involuntary and erratic movements.
Advancements in mortality rates among leading causes of death were cause to celebrate, but the pandemic hampered life expectancy rate improvements.
Chinese officials have said the outbreak is linked to known pathogens, including the influenza virus and the virus that causes Covid-19.
The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.
The man received a pig heart last month and initially made “significant progress.”
The Series B round led by Spark Capital values 5-year old Abridge, which is used by 5,000 doctors, at $200 million. But it’s up against Nuance, which Microsoft bought for $18.8 billion and is used by half a million doctors.